跳到正文
cccskills
免费在 GitHub 公开

enda-genetic-counseling-monogenic-pai

Suggests genetic counseling for patients with primary adrenal insufficiency (PAI) when a monogenic disorder is suspected. Use when PAI patient presents with early-onset disease, syndromic features, consanguinity, family history, or negative autoimmune antibodies.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL

实测评分 未实测

查看安装方法

包含的文件（1）

  • SKILL.md2.6 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Offer Genetic Counseling for Patients with PAI Due to Monogenic Disorders

STEP 1 — Gather Information

Confirm PAI diagnosis via ACTH stimulation test; collect detailed family history (early-onset PAI, consanguinity, related endocrine disorders), assess for syndromic features (e.g., alacrima, achalasia, neurologic signs, hypopigmentation), review autoimmune antibody panel (21‑hydroxylase, adrenal cortex), and note age of onset and clinical phenotype.

STEP 2 — Rule In / Rule Out

Is there a clinical suspicion of a monogenic cause (early-onset PAI <4 years, syndromic features, consanguinity, positive family history, or autoimmune antibody‑negative PAI)? If yes, proceed to classification; if no, consider autoimmune, infectious, or other acquired etiologies and do not routinely offer genetic counseling.

STEP 3 — Classify or Stratify

Sub‑classify the suspected monogenic disorder based on phenotype: adrenal hypoplasia (NR0B1), familial glucocorticoid deficiency (MC2R, MRAP, etc.), Triple A syndrome (AAAS), adrenoleukodystrophy (ABCD1), or other known genes to guide targeted genetic testing panels.

STEP 4 — Decide

Refer the patient (and family) for formal genetic counseling and discuss the benefits, limitations, and implications of targeted or comprehensive genetic testing based on the classification.

Clinical Guardrails / Mimics / Pitfalls

Do not delay life‑saving glucocorticoid or mineralocorticoid replacement while awaiting counseling; avoid offering counseling in patients with clear autoimmune etiology (positive 21‑hydroxylase antibodies) unless atypical features exist; recognize that negative genetic testing does not exclude all monogenic causes; ensure informed consent regarding psychosocial impact and potential insurance implications.

Concrete Clinical Example

A 2‑year‑old boy presents with PAI (hyperpigmentation, hypoglycemia, low cortisol, high ACTH), negative 21‑hydroxylase antibodies, and a history of a sibling who died in infancy with adrenal insufficiency; parents are second cousins. Suspected monogenic PAI → genetic counseling offered → targeted NR0B1 and MC2R testing arranged.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题